Gonzalez-Martinez, Alicia http://orcid.org/0000-0002-1228-1503
Patel, Rohit
Healy, Brian C.
Lokhande, Hrishikesh
Paul, Anu
Saxena, Shrishti
Polgar-Turcsanyi, Mariann
Weiner, Howard L.
Chitnis, Tanuja http://orcid.org/0000-0002-9897-4422
Funding for this research was provided by:
Fulbright Association (Spain-US Fulbright grant)
National Institutes of Health (UH3TR000890)
U.S. Department of Defense (W81XWH1810648)
Article History
Received: 3 March 2023
Accepted: 19 May 2023
First Online: 30 May 2023
Declarations
:
: Written informed consent was obtained from all patients included in the CLIMB Study. This study was approved by the Mass General Brigham Humans Research Committee. This study has been approved by our hospital's Ethics Committee and follows the STARD guidelines.
: Signed informed consent was received from all the patients including consent for publication.
: A. Gonzalez-Martinez has received education funding from Lilly, Novartis, Roche, TEVA, Abbvie-Allergan, & Daichi. B.C. Healy served on the scientific advisory board for Biogen, Worldwide Medical Biostatistics, Multiple Sclerosis, served on the editorial board for Statistical Methods in Medical Research, received research support from Merck Serono, Genzyme, Novartis, Google Life Sciences, NIH, National Multiple Sclerosis Society. H.L. Weiner has consulted for Genentech, Inc; Tiziana Life Sciences; IM Therapeutics; MedDay Pharmaceuticals; vTv Therapeutics; I-MAB Biopharma and received research support National Institutes of Health; National Multiple Sclerosis Society; Sanofi Genzyme; and Genentech, Inc. T. Chitnis served on clinical trial advisory boards for Novartis Pharmaceuticals, Genzyme-Sanofi, consulted for Biogen Idec, Novartis, Genzyme-Sanofi, Genentech Roche, received research support from EMD Serono, Novartis, Biogen, Verily, National Multiple Sclerosis Society, the Peabody Foundation, the Consortium for MS Centers, Guthy-Jackson Charitable Foundation. R. Patel, H. Lokhande, A. Paul, S. Saxena, and M. Polgar-Turcsanyi have no disclosures.